⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Butane SCHEMBL4577044 | 0.87 | — | — | |
| SCHEMBL5964938 | 0.83 | — | — | |
| SCHEMBL29105953 | 0.75 | — | — | |
| SCHEMBL5595739 | 0.75 | — | — | |
| SCHEMBL557762 | 0.72 | — | — | |
| SCHEMBL30478653 | 0.71 | — | — | |
| SCHEMBL8337894 | 0.69 | — | — | |
| SCHEMBL9027634 | 0.69 | — | — | |
| SCHEMBL1533440 | 0.69 | — | — | |
| SCHEMBL28150432 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117597809-A | Nonaqueous electrolyte secondary battery | 松下知识产权经营株式会社 | 2024-02-23 | — | — | CN | claimed |
| CN-108064426-B | Electrolyte formulation for lithium ion batteries | 野猫技术开发公司 | 2021-07-30 | — | — | CN | claimed |
| EP-4704975-A1 | NOVEL PHOSPHOANTIGEN PRODRUG COMPOUND AND USE THEREOF | University College Cardiff Consultants, Ltd. (GB) | 2026-03-11 | — | — | EP | disclosed |
| CN-119421880-A | Condensed with pesticidal activity bicyclic heteroaromatic compounds | 先正达农作物保护股份公司 | 2025-02-11 | — | — | CN | disclosed |
| EP-4499656-A1 | STAT MODULATORS AND USES THEREOF | Recludix Pharma, Inc. (US) | 2025-02-05 | — | — | EP | disclosed |
| WO-2024231319-A1 | NOVEL PHOSPHOANTIGEN PRODRUG COMPOUND AND USE THEREOF | UNIVERSITY COLLEGE CARDIFF CONSULTANTS LTD (GB) | 2024-11-14 | — | — | WO | disclosed |
| EP-4458412-A1 | NOVEL PHOSPHOANTIGEN PRODRUG COMPOUND AND USE THEREOF | University College Cardiff Consultants, Ltd. (GB) | 2024-11-06 | — | — | EP | disclosed |
| WO-2024096450-A1 | ELECTROLYTE ADDITIVE, AND BATTERY ELECTROLYTE COMPRISING SAME AND SECONDARY BATTERY COMPRISING SAME | 솔브레인 주식회사 | 2024-05-10 | — | — | WO | disclosed |
| CN-117915956-A | M6PR cell surface receptor binding compounds and conjugates | 利西亚治疗公司 | 2024-04-19 | — | — | CN | disclosed |
| CN-117597809-A | Nonaqueous electrolyte secondary battery | 松下知识产权经营株式会社 | 2024-02-23 | — | — | CN | disclosed |
| WO-2023192960-A1 | STAT MODULATORS AND USES THEREOF | RECLUDIX PHARMA, INC. (US) | 2023-10-05 | — | — | WO | disclosed |
| EP-1242432-A1 | PHOSPHONIC ACID DERIVATIVES AS INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE 1B (PTP-1B) | MERCK FROSST CANADA INC. (CA) | 2002-09-25 | — | — | EP | disclosed |
| US-20020052344-A1 | Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase IB (PTP-IB) | MERCK FROSST CANADA LTD. (CA) | 2002-05-02 | — | — | US | disclosed |
| EP-1115729-A1 | PHOSPHONIC ACID DERIVATIVES AS INHIBITORS OF PTP-1B | Merck Frosst Canada & Co. (CA) | 2001-07-18 | — | — | EP | disclosed |
| WO-2001046205-A1 | PHOSPHONIC ACID DERIVATIVES AS INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE 1B (PTP-1B) | MERCK FROSST CANADA & CO. (CA) | 2001-06-28 | — | — | WO | disclosed |
| US-6174874-B1 | ANTIDIABETIC,-CARCINOGENIC AGENTS; IMPROVING GLUCOSE TOLERANCE/INSULIN-SENSITIVITY; PREVENTING/TREATING OBESITY AND NEURODEGENERATIVE DISEASES; E.G. 1,3-BIS-((PHOSPHONODI-FLUOROMETHYL)PHENYL)-2-DICARBOXYPROPANE | MERCK FROSST CANADA & CO. (CA) | 2001-01-16 | — | — | US | disclosed |
| WO-2000017211-A1 | PHOSPHONIC ACIDS DERIVATIVES AS INHIBITORS OF PTP-1B | MERCK FROSST CANADA & CO. (CA) | 2000-03-30 | — | — | WO | disclosed |
| CN-1235548-A | Method for lowering plasma levels of lipoprotein (A) | SCHERING AG (DE) | 1999-11-17 | — | — | CN | disclosed |
| WO-1997045411-A9 | ANALOGS OF CC-1065 AND THE DUOCARMYCINS | — | 1998-04-09 | — | — | WO | disclosed |
| EP-0335770-B1 | Novel fluorophosphonate nucleotide derivatives | MERRELL PHARMA INC (US) | 1997-01-15 | — | — | EP | disclosed |